Official Sections CTRMS ISVCA IPITA IPTA ISODP IRTA IXA SPLIT TID

TTS-IRTA AHP Webinar - Thursday, February 27, 2020 - 4:00 PM EST (Montreal time)

IRTA Allied Health Providers Webinar Series: Updates in Patient Care

Pediatric Intestinal Failure and Transplant: Updates in Patient Care
Thursday, February 27, 2020 - 4:00 PM EST (Montreal time)

Discussant: Stephanie So, MSc. PT
Physiotherapist
The Hospital for Sick Children, Toronto
Transplant and Regenerative Medicine Centre
Group for Improvement of Intestinal Function and Treatment (GIFT)
University of Toronto
Toronto, ON, Canada
Discussant: Brooke Chapman, APD
Senior Clinician, Nutrition & Dietetics
Liver & Intestinal Transplant Unit. PhD Candidate
Austin Health
Victoria, Australia
Discussant: Carly Bambridge, CNS, RN
Clinical Nurse Specialist, Paediatric Intestinal Transplant
King's College Hospital
Institute of Liver Studies
Denmark Hill, London, UK
Moderator: Beverly Kosmach-Park, DNP, RN, FAAN
Clinical Nurse Specialist
Department of Transplant Surgery
Children's Hospital of Pittsburgh
Pittsburgh, PA, USA

Webinar Summary:

The Allied Health Provider Committee of IRTA is pleased to present the first webinar of the Allied Health 2020 Speaker Series. This webinar will focus on patient care strategies and outcomes within intestinal rehabilitation and transplant. The topics presented will provide updates focusing on nutritional interventions and physical outcomes in intestinal failure as well as analgesia post-intestine transplant.   Each presentation will be 15 minutes in length followed by a 5-minute question period. 

Growth Factors in Intestinal Failure

Brooke Chapman, APD

Brooke Chapman, BAppSci, Masters (Nutrition and Dietetics), Accredited Practising Dietitian, PhD (c)
Brooke is a senior clinical dietitian from Melbourne, Australia, and has worked in the Liver and Intestinal Transplant Unit at Austin Health for almost 15 years. She is experienced in the nutritional management of liver disease, intestinal failure and transplant. Brooke is active in clinical research to enhance outcomes for these patients with complex nutritional needs and is currently undertaking a PhD in this area.
Following participation in this session, the learner will be able to:

  1. Develop an awareness of growth factors currently available for clinical use in patients with SBS-IF.
  2. Have a general understanding of the mechanism of action of GLP-2 and how it enhances enteral absorption.
  3. Describe the most recent ‘real-world’ outcomes of patients with SBS-IF treated with teduglutide.

Physical Activity, Strength and Fatigue in Children with Intestinal Failure on Parenteral Nutrition

Stephanie So, MSc. PT

Stephanie is a physiotherapist from SickKids in Toronto, Canada and works in the Liver and Intestinal Transplant and Intestinal Rehabilitation Program (GIFT).  She is also a lecturer at the University of Toronto. Stephanie has published on neurodevelopmental outcomes and physical function in children with intestinal failure, and physical function and activity outcomes in children post liver transplant. She is an active member of the IRTA Allied Health Committee.
Following participation in this session, the learner will be able to:

  1. Summarize current research findings looking at motor skills, strength and physical function in children with intestinal failure.
  2. Discuss differences in physical activity, strength, fatigue and physical function in children with intestinal failure compared to healthy controls.
  3. List several variables that may impact strength and agility in this population.

Analgesia Requirements for Patients with Chronic Intestinal Pseudo-Obstruction (CIPO) Post-Intestine Transplant

Carly Bambridge, CNS, RN

Carly is the lead nurse for Intestinal Transplantation at King’s College Hospital, London. Her role includes support and education for patients and their families from transplant assessment and continuing through long term follow-up after transplant. She is a member of the IRTA Allied Health Provider committee and has been involved in the organisation of the United Kingdom Small Bowel Transplant Meetings. She is also a member of the Multi-visceral and Composite Tissue Advisory Group (MCTAG) which advises the NHS Blood and Transplant service. Carly’s interests include health promotion post-transplant, the development of services to meet the needs of patients undergoing multi-visceral transplantation, and burden of care post-transplant.

Following participation in this session, the learner will be able to:

  1. Discuss two symptoms that patients with CIPO may experience as part of this disorder.
  2. List two reasons why pain may have an impact on recovery following intestinal transplantation.
  3. Identify a patient you have cared for post-transplant. Reflect on the pain management strategy and the patient's underlying diagnosis. Were there any issues with pain management post-operatively?

Moderator

Beverly Kosmach-Park, DNP, RN, FAAN

Beverly is a Clinical Nurse Specialist for the Department of Transplant Surgery at Children’s Hospital of Pittsburgh. She works with liver and intestine transplant patients and their families from evaluation through chronic care post-transplant. Beverly is Chair of the Allied Health Providers Committee of IRTA and on the Board of Directors of IRTA.

Local Times:

Thursday, February 27, 2020 - 4:00 PM EST (Montreal time)

AccraThu 21:00Casablanca *Thu 22:00KolkataFri 02:30ReykjavikThu 21:00
Addis AbabaFri 00:00ChicagoThu 15:00Kuala LumpurFri 05:00Rio de JaneiroThu 18:00
Adelaide *Fri 07:30CopenhagenThu 22:00Kuwait CityFri 00:00RiyadhFri 00:00
AlgiersThu 22:00DallasThu 15:00KyivThu 23:00RomeThu 22:00
AlmatyFri 03:00Dar es SalaamFri 00:00La PazThu 17:00Salt Lake CityThu 14:00
AmmanThu 23:00DarwinFri 06:30LagosThu 22:00San FranciscoThu 13:00
AmsterdamThu 22:00DenverThu 14:00LahoreFri 02:00San JuanThu 17:00
AnadyrFri 09:00DetroitThu 16:00Las VegasThu 13:00San SalvadorThu 15:00
AnchorageThu 12:00DhakaFri 03:00LimaThu 16:00Santiago *Thu 18:00
AnkaraFri 00:00DohaFri 00:00LisbonThu 21:00Santo DomingoThu 17:00
AntananarivoFri 00:00DubaiFri 01:00LondonThu 21:00São PauloThu 18:00
Asuncion *Thu 18:00DublinThu 21:00Los AngelesThu 13:00SeattleThu 13:00
AthensThu 23:00EdmontonThu 14:00MadridThu 22:00SeoulFri 06:00
AtlantaThu 16:00FrankfurtThu 22:00ManaguaThu 15:00ShanghaiFri 05:00
Auckland *Fri 10:00Guatemala CityThu 15:00ManilaFri 05:00SingaporeFri 05:00
BaghdadFri 00:00HalifaxThu 17:00Melbourne *Fri 08:00SofiaThu 23:00
BangaloreFri 02:30HanoiFri 04:00Mexico CityThu 15:00St. John'sThu 17:30
BangkokFri 04:00HarareThu 23:00MiamiThu 16:00StockholmThu 22:00
BarcelonaThu 22:00HavanaThu 16:00MinneapolisThu 15:00SuvaFri 09:00
BeijingFri 05:00HelsinkiThu 23:00MinskFri 00:00Sydney *Fri 08:00
BeirutThu 23:00Hong KongFri 05:00MontevideoThu 18:00TaipeiFri 05:00
BelgradeThu 22:00HonoluluThu 11:00MontréalThu 16:00TallinnThu 23:00
BerlinThu 22:00HoustonThu 15:00MoscowFri 00:00TashkentFri 02:00
BogotaThu 16:00IndianapolisThu 16:00MumbaiFri 02:30TegucigalpaThu 15:00
BostonThu 16:00IslamabadFri 02:00NairobiFri 00:00TehranFri 00:30
BrasiliaThu 18:00IstanbulFri 00:00NassauThu 16:00TokyoFri 06:00
BrisbaneFri 07:00JakartaFri 04:00New DelhiFri 02:30TorontoThu 16:00
BrusselsThu 22:00JerusalemThu 23:00New OrleansThu 15:00VancouverThu 13:00
BucharestThu 23:00JohannesburgThu 23:00New YorkThu 16:00ViennaThu 22:00
BudapestThu 22:00KabulFri 01:30OsloThu 22:00WarsawThu 22:00
Buenos AiresThu 18:00KarachiFri 02:00OttawaThu 16:00Washington DCThu 16:00
CairoThu 23:00KathmanduFri 02:45ParisThu 22:00WinnipegThu 15:00
CalgaryThu 14:00KhartoumThu 23:00PerthFri 05:00YangonFri 03:30
Canberra *Fri 08:00KingstonThu 16:00PhiladelphiaThu 16:00ZagrebThu 22:00
Cape TownThu 23:00KinshasaThu 22:00PhoenixThu 14:00ZürichThu 22:00
CaracasThu 17:00KiritimatiFri 11:00PragueThu 22:00

* Adjusted for Daylight Saving Time (8 places).
Thu = Thursday, February 27, 2020 (93 places).
Fri = Friday, February 28, 2020 (50 places).
Local time for Montréal: Thursday, February 27, 2020 at 16:00:00
UTC (GMT/Zulu)-time: Thursday, February 27, 2020 at 21:00:00
UTC is Coordinated Universal Time, GMT is Greenwich Mean Time.

Read more: TTS-IRTA AHP Webinar - Thursday, February 27, 2020 - 4:00 PM EST (Montreal time)

TTS Education Committee Webinar - Monday, January 27, 2020 3:00PM EST (Montreal time)

Please note, this webinar has been cancelled. We will notify you when it is rescheduled. We apologize for the inconvenience.

TTS Education Committee: Joint TTS-ISVCA Webinar Series on Composite Tissue

TITLE: Immunology of VCA
Monday, January 27, 2020 3:00PM EST (Montreal time)

Discussant: Gerald Brandacher, MD
Professor
Vice Chair of Research
Director, Interdisciplinary Research and Innovation for the Surgical Sciences
Scientific Director, Reconstructive Transplantation Program
Director, Vascularized Composite Allotransplantation (VCA) Laboratory
Department of Plastic and Reconstructive Surgery
Johns Hopkins University School of Medicine
Baltimore, MD, USA

Discussant: Rolf N. Barth, MD
Professor of Surgery
Head, Division of Transplantation
Director, Liver Transplantation
University of Maryland School of Medicine
Baltimore, MD, USA

Objectives:

To provide an overview on similarities and differences identified in VCA vs solid organ transplants.

Gerald Brandacher's Biography:

Dr. Gerald Brandacher is an associate professor of surgery and plastic and reconstructive surgery at Johns Hopkins University School of Medicine. He serves as the scientific director of the Reconstructive Transplantation Program at the Johns Hopkins School of Medicine.

His team is engaged in basic and translational research on donor-specific immune tolerance and immunomonitoring strategies for Vascularized Composite Allotransplantation (VCA) such as hand, upper extremity, and face transplants.

Prior to joining Johns Hopkins, Dr. Brandacher was a key member of the hand transplant program at the University of Pittsburgh Medical Center (UPMC). He was instrumental in designing a novel cell-based immunomodulatory treatment protocol for composite tissue allotransplantation and was also part of the team performing the first bilateral hand transplant and first forearm transplant in the United States.

Dr. Brandacher has mentored 60 pre- and post-doctoral researches over the past 15 years, and has authored more than 180 peer reviewed papers, 27 book chapters, and has edited two textbooks on hand transplantation. In 2014, he co-founded the journal Vascularized Composite Allotransplantation (VCA), and currently serves as its Editor-in-Chief. Dr. Brandacher is the principal investigator of multiple major federal research grants on projects related to upper extremity transplantation, cell-based immune modulation, and tolerance induction. He has given over 130 invited lectures and has been a visiting professor around the world and at leading American medical institutions.

Dr. Brandacher has served as the President of the Austrian Society of Surgical Research (2008-2009) and as Chair of the American Society of Transplantation (AST) Vascular Composite Allotransplantation Advisory Council (2014-15). He was elected as Chair of the Vascularized Composite Allotransplantation Committee of the European Society of Organ Transplantation (ESOT) in 2015, and is a Founding Member of the American Society of Reconstructive Transplantation (ASRT), for which he currently serves as the President Elect. He is a Member at Large to the OPTN/UNOS Vascularized Composite Allograft Transplantation (VCA) Committee. In 2015 he was selected as a “Fellow of the American Society of Transplantation”.

Rolf N. Barth's Biography:

Dr. Rolf Barth is an professor of surgery at the University of Maryland School of Medicine, the head of the Division of Transplantation and the director of liver transplantation at UM Medical Center. His clinical practice focuses on kidney, pancreas, and liver transplantation. Dr. Barth received his medical degree and surgical training at Duke University and continued specialty training in transplant surgery at University of Wisconsin-Madison. Dr. Barth also performed post-doctoral training in transplant immunology at Massachusetts General Hospital/Harvard Medical School. Dr. Barth has active clinical and basic research interests that include novel immunosuppressive therapies, immunologic tolerance, and the use of genetically engineered animal organs for human transplantation (xenotransplantation). Dr. Barth has an active lab investigating transplant tolerance and pre-clinical models of composite facial and limb transplantation towards the clinical goal of reconstructive transplantation. These efforts were part of one of the most-extensive face transplant performed worldwide to date.

Local Times:

Monday, January 27, 2020 3:00PM EST (Montreal time)

AccraMon 20:00Casablanca *Mon 21:00KolkataTue 01:30ReykjavikMon 20:00
Addis AbabaMon 23:00ChicagoMon 14:00Kuala LumpurTue 04:00Rio de JaneiroMon 17:00
Adelaide *Tue 06:30CopenhagenMon 21:00Kuwait CityMon 23:00RiyadhMon 23:00
AlgiersMon 21:00DallasMon 14:00KyivMon 22:00RomeMon 21:00
AlmatyTue 02:00Dar es SalaamMon 23:00La PazMon 16:00Salt Lake CityMon 13:00
AmmanMon 22:00DarwinTue 05:30LagosMon 21:00San FranciscoMon 12:00
AmsterdamMon 21:00DenverMon 13:00LahoreTue 01:00San JuanMon 16:00
AnadyrTue 08:00DetroitMon 15:00Las VegasMon 12:00San SalvadorMon 14:00
AnchorageMon 11:00DhakaTue 02:00LimaMon 15:00Santiago *Mon 17:00
AnkaraMon 23:00DohaMon 23:00LisbonMon 20:00Santo DomingoMon 16:00
AntananarivoMon 23:00DubaiTue 00:00LondonMon 20:00São PauloMon 17:00
Asuncion *Mon 17:00DublinMon 20:00Los AngelesMon 12:00SeattleMon 12:00
AthensMon 22:00EdmontonMon 13:00MadridMon 21:00SeoulTue 05:00
AtlantaMon 15:00FrankfurtMon 21:00ManaguaMon 14:00ShanghaiTue 04:00
Auckland *Tue 09:00Guatemala CityMon 14:00ManilaTue 04:00SingaporeTue 04:00
BaghdadMon 23:00HalifaxMon 16:00Melbourne *Tue 07:00SofiaMon 22:00
BangaloreTue 01:30HanoiTue 03:00Mexico CityMon 14:00St. John'sMon 16:30
BangkokTue 03:00HarareMon 22:00MiamiMon 15:00StockholmMon 21:00
BarcelonaMon 21:00HavanaMon 15:00MinneapolisMon 14:00SuvaTue 08:00
BeijingTue 04:00HelsinkiMon 22:00MinskMon 23:00Sydney *Tue 07:00
BeirutMon 22:00Hong KongTue 04:00MontevideoMon 17:00TaipeiTue 04:00
BelgradeMon 21:00HonoluluMon 10:00MontréalMon 15:00TallinnMon 22:00
BerlinMon 21:00HoustonMon 14:00MoscowMon 23:00TashkentTue 01:00
BogotaMon 15:00IndianapolisMon 15:00MumbaiTue 01:30TegucigalpaMon 14:00
BostonMon 15:00IslamabadTue 01:00NairobiMon 23:00TehranMon 23:30
BrasiliaMon 17:00IstanbulMon 23:00NassauMon 15:00TokyoTue 05:00
BrisbaneTue 06:00JakartaTue 03:00New DelhiTue 01:30TorontoMon 15:00
BrusselsMon 21:00JerusalemMon 22:00New OrleansMon 14:00VancouverMon 12:00
BucharestMon 22:00JohannesburgMon 22:00New YorkMon 15:00ViennaMon 21:00
BudapestMon 21:00KabulTue 00:30OsloMon 21:00WarsawMon 21:00
Buenos AiresMon 17:00KarachiTue 01:00OttawaMon 15:00Washington DCMon 15:00
CairoMon 22:00KathmanduTue 01:45ParisMon 21:00WinnipegMon 14:00
CalgaryMon 13:00KhartoumMon 22:00PerthTue 04:00YangonTue 02:30
Canberra *Tue 07:00KingstonMon 15:00PhiladelphiaMon 15:00ZagrebMon 21:00
Cape TownMon 22:00KinshasaMon 21:00PhoenixMon 13:00ZürichMon 21:00
CaracasMon 16:00KiritimatiTue 10:00PragueMon 21:00

* Adjusted for Daylight Saving Time (8 places).
Mon = Monday, January 27, 2020 (106 places).
Tue = Tuesday, January 28, 2020 (37 places).
Local time for Montréal: Monday, January 27, 2020 at 15:00:00
UTC (GMT/Zulu)-time: Monday, January 27, 2020 at 20:00:00
UTC is Coordinated Universal Time, GMT is Greenwich Mean Time.

Read more: TTS Education Committee Webinar - Monday, January 27, 2020 3:00PM EST (Montreal time)

Social

Contact

Staff Directory
+1-514-874-1717
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada